U.S. Paper and Forestry Products Stock News

NYSE:NNN
NYSE:NNNRetail REITs

NNN REIT Extends Dividend Streak As Record 2025 Acquisitions Test Balance Sheet

NNN REIT (NYSE:NNN) reported a 36th consecutive year of dividend increases in 2025. The company recorded its highest ever annual acquisition volume, with more than $900m invested in new properties. NNN REIT highlighted a portfolio with high occupancy and long lease terms alongside this expansion. NNN REIT enters 2026 with a long dividend growth streak that sets it apart from many other U.S. listed companies. Its shares recently traded at $44.34, with the stock up 3.3% over the past week,...
NYSE:JBS
NYSE:JBSFood

Assessing JBS (NYSE:JBS) Valuation After Recent Share Price Momentum

What JBS stock’s recent move might be telling you JBS (NYSE:JBS) has attracted fresh attention after a recent share price move, with the stock up about 1.1% over the past week and roughly 9.1% over the past month. See our latest analysis for JBS. The recent 30 day share price return of 9.1% and 90 day return of 15.4% suggest building momentum for JBS, with the current share price at $16.0 anchoring those shorter term moves. If this has you thinking about where else momentum could be forming,...
NYSE:U
NYSE:USoftware

Unity Board Refresh Brings Bernard Kim And New Governance Focus

Unity Software (NYSE:U) is reshaping its Board of Directors, with Bernard Kim set to join as an independent director. Longtime directors including founder David Helgason and Tomer Bar Zeev are retiring from the board, with Mary Schmidt Campbell also scheduled to step down. These changes mark a material shift in Unity's board composition and corporate oversight. Unity runs a widely used real time 3D engine and toolset that powers many mobile and console games, as well as applications in...
NYSE:PGR
NYSE:PGRInsurance

A Look At Progressive (PGR) Valuation After Strong Results And Renewed Analyst Optimism

Progressive (PGR) is back in focus after several major banks reaffirmed positive views following strong December and quarterly results, as rising net premiums and solid profitability metrics draw fresh attention from insurance sector investors. See our latest analysis for Progressive. At a share price of $204.53, Progressive’s 1-day share price return of a 0.45% decline and 90-day share price return of a 9.24% decline compare with a 5-year total shareholder return of 162.88%. This indicates...
NasdaqGS:CG
NasdaqGS:CGCapital Markets

A Look At Carlyle Group (CG) Valuation After Fourth Quarter Earnings Beat And Positive Analyst Reaction

Carlyle Group (CG) is back in focus after reporting fourth quarter results that topped Wall Street expectations on both revenue and non GAAP earnings per share, prompting a broadly positive reaction from analysts. See our latest analysis for Carlyle Group. Carlyle’s recent earnings beat, dividend affirmation and ongoing share buybacks come against a share price that has pulled back, with a 30 day share price return of 16.96% and a year to date share price decline of 10.47%, even as the 1 year...
NYSE:GATX
NYSE:GATXTrade Distributors

Should Slower Railcar Uptake and Liquidity Strains Require Action From GATX (GATX) Investors?

In recent days, GATX’s business update highlighted slower-than-hoped adoption of its railcar solutions, rising cash burn, and a tight liquidity position that could require fresh equity financing. At the same time, the company has attracted strong institutional interest and AI-driven trading support, with market participants emphasizing operational momentum and long-term leasing fundamentals despite these financial pressures. We’ll now examine how this mix of robust institutional support and...
NasdaqGS:TECH
NasdaqGS:TECHLife Sciences

Assessing Bio-Techne (TECH) Valuation After Earnings Beat And New 3D Research Tool Launch

Why Bio-Techne Is Back on Investor Radar Bio-Techne (TECH) has drawn fresh attention after quarterly results topped Wall Street expectations, supported by large pharmaceutical customers, tighter cost control and new product momentum in 3D stem cell and organoid research tools. See our latest analysis for Bio-Techne. Those earnings and product updates have landed against a mixed share price backdrop, with a 12.73% 1 month share price decline and an 8.58% 1 year total shareholder return...
NYSE:WEX
NYSE:WEXDiversified Financial

WEX (WEX) EPS Jump In Q4 Reinforces Bullish Long Term Earnings Narratives

WEX (WEX) has just wrapped up FY 2025 with Q4 revenue of US$672.9 million and basic EPS of US$2.45, while full year trailing twelve month revenue came in at about US$2.7 billion and EPS at US$8.57. Over recent quarters the company has seen revenue move from US$636.5 million in Q4 2024 to US$672.9 million in Q4 2025, with basic EPS shifting from US$1.62 to US$2.45 over the same period, giving investors a clear view of how the top and bottom lines have tracked into this latest print. With a...
NYSE:THG
NYSE:THGInsurance

Does Hanover Insurance Group (THG) Offer Value After Strong Five Year Share Price Gains

If you are wondering whether Hanover Insurance Group's share price still reflects its underlying worth, this article walks through the key numbers that matter before you commit fresh capital. The stock closed at US$171.80, with returns of 1.1% over 30 days, 7.8% over 1 year, 29.3% over 3 years and 70.4% over 5 years. This recent price history gives useful context for judging current value and risk. Recent coverage has focused on Hanover Insurance Group's position in the US insurance sector...
NYSE:EHC
NYSE:EHCHealthcare

Is It Too Late To Consider Encompass Health (EHC) After Strong Multi‑Year Share Gains?

For investors wondering whether Encompass Health at around US$110 a share still offers value, or if the easy money has already been made, this article explains what the current price reflects. The stock has returned 4.5% over the last 7 days, 9.6% over 30 days, 3.5% year to date, 9.9% over 1 year, 79.3% over 3 years and 81.5% over 5 years. These figures naturally raise questions about what is now priced in. Recent attention on Encompass Health has focused on its position within US healthcare...
NasdaqGS:ROIV
NasdaqGS:ROIVBiotechs

Roivant Sciences Advances PHocus Trial Milestone As Shares Trade Below Targets

Pulmovant, a Roivant Sciences company, has completed patient enrollment in the Phase 2 PHocus trial of mosliciguat for pulmonary hypertension associated with interstitial lung disease. Enrollment finished ahead of schedule, marking a key clinical milestone for this potential first in class inhaled therapy. For investors watching Roivant Sciences (NasdaqGS:ROIV), this clinical update adds fresh context to a stock that has seen a very large 1 year return and a 20.6% gain year to date. Shares...
NYSE:FTV
NYSE:FTVMachinery

Does Fortive’s (FTV) Buyback And Recurring Revenue Push Hint At A Shifting Risk Profile?

In early February 2026, Fortive Corporation reported fourth-quarter 2025 sales of US$1,122.5 million with continuing operations EPS edging higher year on year, even as full-year net income fell to US$579.2 million on modestly higher sales of US$4,159.1 million. Alongside these results, Fortive completed a multi-year buyback program totaling 43,483,303 shares for US$2,734.24 million, while management highlighted expanding recurring revenue and strong demand in its Fluke and international...
NYSE:SYY
NYSE:SYYConsumer Retailing

A Look At Sysco (SYY) Valuation After Its New $1.25b Senior Notes Issue

Why Sysco’s new $1.25b in senior notes matters for stock watchers Sysco (SYY) has just issued $1.25b of new senior notes, mainly to refinance commercial paper and support general corporate uses. This gives stock investors fresh information about its capital structure and debt profile. See our latest analysis for Sysco. The new senior notes come as Sysco’s share price has gained 14.9% over the past month and 20.5% over the last 90 days, with a 1 year total shareholder return of 30.9%. This...
NYSE:NPO
NYSE:NPOMachinery

Has The Rally In Enpro (NPO) Gone Too Far After Strong Multi‑Year Gains?

Investors may be wondering whether Enpro is still fairly priced after a strong run, or if the current level is starting to look stretched for new money going in. The stock last closed at US$272.63, with returns of 1.9% over 7 days, 12.0% over 30 days, 24.4% year to date, 42.2% over 1 year, 133.4% over 3 years and 265.3% over 5 years. This naturally raises questions about what is already reflected in the price. Recent coverage of Enpro has focused on its position in the capital goods space...
NasdaqGS:EXTR
NasdaqGS:EXTRCommunications

A Look At Extreme Networks (EXTR) Valuation After New AI Platform ONE Launch For K 12 Networking

Extreme Networks (EXTR) is in focus after announcing E-Rate eligible networking solutions for K-12 schools and libraries, centered on its new AI powered Extreme Platform ONE and supporting Wi-Fi, switching, and fabric products. See our latest analysis for Extreme Networks. At a share price of US$14.46, Extreme Networks has seen a 2.26% 1 day share price return. The 30 day and year to date share price returns of 9.40% and 12.58% suggest momentum has been fading despite the new K 12 focused AI...
NYSE:ELF
NYSE:ELFPersonal Products

Is It Too Late To Consider e.l.f. Beauty (ELF) After Strong Five Year Share Gains?

If you are wondering whether e.l.f. Beauty's share price still lines up with its underlying worth, this article will walk through what the current numbers are actually telling you. The stock most recently closed at US$81.50, with a 0.7% decline over 7 days, a 9.4% decline over 30 days, a 4.7% gain year to date, an 11.6% gain over 1 year and a very large gain over 5 years. Recent news flow around e.l.f. Beauty has focused on its position as a mass market cosmetics brand that aims to compete...
NYSE:ARLO
NYSE:ARLOElectronic

Arlo Insider Sale Prompts Fresh Look At Valuation And Earnings Expectations

Arlo Technologies (NYSE:ARLO) reported an insider share sale in a recent SEC filing. The transaction involved an internal company figure disposing of a meaningful block of shares. The filing brings a fresh data point for investors watching insider sentiment around Arlo. Arlo Technologies focuses on connected security cameras and smart home monitoring products, an area that continues to attract interest from consumers and enterprises. For investors, insider activity at NYSE:ARLO sits...
NYSE:EXP
NYSE:EXPBasic Materials

How Dividend Hike, Buybacks and New Institutional Stake At Eagle Materials (EXP) Has Changed Its Investment Story

Eagle Materials’ board has declared a quarterly cash dividend of $0.25 per share, payable on April 13, 2026, to shareholders of record as of March 16, 2026, while Black Creek Investment Management Inc. recently acquired 502,120 shares valued at about $104 million. The combination of solid cement and aggregates volume growth, active share repurchases, and fresh institutional interest highlights how Eagle Materials is deploying capital to support operations and shareholders. We’ll now examine...
NasdaqGS:GILD
NasdaqGS:GILDBiotechs

Did Gilead’s (GILD) Strong Quarter, Bigger Dividend and Yescarta Win Just Redefine Its Story?

In February 2026, Gilead Sciences reported higher fourth-quarter and full-year 2025 revenue and earnings, raised its quarterly dividend to US$0.82 per share, completed a multi-year US$4.15 billion buyback program, and received FDA approval to remove key prescribing limitations for its Yescarta CAR T-cell therapy in certain lymphoma patients. Together, these moves highlight Gilead’s emphasis on returning cash to shareholders while trying to widen its oncology footprint alongside its...
NYSE:UNH
NYSE:UNHHealthcare

UnitedHealth Group (UNH) Is Up 6.0% After Soft Earnings And Medicare Advantage Jitters - Has The Bull Case Changed?

In early February 2026, analysts and investors reacted to UnitedHealth Group’s recent earnings, which showed weaker-than-expected revenue, rising medical costs, and cautious guidance amid regulatory uncertainty around Medicare Advantage. These developments have intensified focus on how policy proposals for flat Medicare Advantage rates in 2027 and slower earnings recovery could affect UnitedHealth’s core Medicare and Optum franchises. We’ll now examine how concerns about a slower earnings...
NYSE:SSB
NYSE:SSBBanks

Does New Client-Service Awards Momentum Clarify SouthState Bank’s (SSB) Competitive Edge in Business Banking?

In early February 2026, SouthState Bank Corporation was recognized by Crisil Coalition Greenwich with 29 awards in U.S. Middle Market and Small Business Banking, the second highest total nationally and an increase of six awards from the prior year. This expanded recognition, including a tie for the highest number of Middle Market Banking awards, underlines SouthState’s strengthening position among regional and super-regional institutions and highlights the depth of its client relationships...
NasdaqGS:CMCSA
NasdaqGS:CMCSATelecom

Is Comcast (CMCSA) Offering Long Term Value After Multi Year Share Price Weakness

If you are wondering whether Comcast's current share price reflects its underlying value, this breakdown is designed to help you make sense of what you are paying for. The stock last closed at US$31.57, with returns of 0.6% over 7 days, 13.5% over 30 days, 6.9% year to date, and a 0.9% decline over 1 year, plus longer term returns of a 4.8% decline over 3 years and a 25.1% decline over 5 years. These moves sit against a backdrop of ongoing interest in Comcast's broadband and media footprint,...
NasdaqGS:CASY
NasdaqGS:CASYConsumer Retailing

The Bull Case For Casey's General Stores (CASY) Could Change Following Q2 Earnings Beat, Store Growth And Higher EBITDA Guidance – Learn Why

Casey’s General Stores recently paid a quarterly dividend of US$0.57 per share on 13 February 2026, alongside reporting 14% Q2 fiscal 2026 earnings growth and 9% store expansion, with management guiding to 15–17% EBITDA growth for the full fiscal year. This combination of earnings momentum, ongoing network growth, and a steadily rising, though modest, dividend highlights how Casey’s is balancing reinvestment in the business with direct cash returns to shareholders. With management now...
NasdaqGS:HAS
NasdaqGS:HASLeisure

Hasbro Bets On Partnerships And Digital Ads To Power Growth

Hasbro unveiled new products at the North American International Toy Fair, including its first Peppa Pig toy featuring a character with a hearing aid and an upcoming Magic: The Gathering "Universes Beyond" set. The company announced multi-year licensing agreements, highlighted by a new Harry Potter toy partnership with Warner Bros. Hasbro also introduced a digital advertising joint venture with Animaj focused on kids' entertainment content across digital platforms. For investors watching...